136 related articles for article (PubMed ID: 9575085)
21. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.
Tolosa E; Li W; Yasuda Y; Wienhold W; Denzin LK; Lautwein A; Driessen C; Schnorrer P; Weber E; Stevanovic S; Kurek R; Melms A; Bromme D
J Clin Invest; 2003 Aug; 112(4):517-26. PubMed ID: 12925692
[TBL] [Abstract][Full Text] [Related]
22. Splenic cathepsin L is maturated from the proform by interferon-gamma after immunization with exogenous antigens.
Zhang T; Maekawa Y; Sakai T; Nakano Y; Ishii K; Hisaeda H; Kominami E; Katunuma N; Asao T; Himeno K
Biochem Biophys Res Commun; 2001 May; 283(2):499-506. PubMed ID: 11327729
[TBL] [Abstract][Full Text] [Related]
23. Proteases involved in MHC class II antigen presentation.
Villadangos JA; Bryant RA; Deussing J; Driessen C; Lennon-Duménil AM; Riese RJ; Roth W; Saftig P; Shi GP; Chapman HA; Peters C; Ploegh HL
Immunol Rev; 1999 Dec; 172():109-20. PubMed ID: 10631941
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages.
Beers C; Honey K; Fink S; Forbush K; Rudensky A
J Exp Med; 2003 Jan; 197(2):169-79. PubMed ID: 12538657
[TBL] [Abstract][Full Text] [Related]
25. The p41 isoform of invariant chain is a chaperone for cathepsin L.
Lennon-Duménil AM; Roberts RA; Valentijn K; Driessen C; Overkleeft HS; Erickson A; Peters PJ; Bikoff E; Ploegh HL; Wolf Bryant P
EMBO J; 2001 Aug; 20(15):4055-64. PubMed ID: 11483509
[TBL] [Abstract][Full Text] [Related]
26. Thyroglobulin type-I-like domains in invariant chain fusion proteins mediate resistance to cathepsin L digestion.
Hitzel C; Kanzler H; König A; Kummer MP; Brix K; Herzog V; Koch N
FEBS Lett; 2000 Nov; 485(1):67-70. PubMed ID: 11086167
[TBL] [Abstract][Full Text] [Related]
27. Requirements of exogenous protein antigens for presentation to CD4+ T lymphocytes by MHC class II-positive APC.
Gradehandt G; Hampl J; Kleber N; Lobron C; Milbradt S; Schmidt B; Rüde E
Adv Exp Med Biol; 1993; 329():23-7. PubMed ID: 8104374
[No Abstract] [Full Text] [Related]
28. Antigen presentation and T cell development in H2-M-deficient mice.
Fung-Leung WP; Surh CD; Liljedahl M; Pang J; Leturcq D; Peterson PA; Webb SR; Karlsson L
Science; 1996 Mar; 271(5253):1278-81. PubMed ID: 8638109
[TBL] [Abstract][Full Text] [Related]
29. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation.
Hsieh CS; deRoos P; Honey K; Beers C; Rudensky AY
J Immunol; 2002 Mar; 168(6):2618-25. PubMed ID: 11884425
[TBL] [Abstract][Full Text] [Related]
30. Cloning of a novel MHC-encoded serine peptidase highly expressed by cortical epithelial cells of the thymus.
Bowlus CL; Ahn J; Chu T; Gruen JR
Cell Immunol; 1999 Sep; 196(2):80-6. PubMed ID: 10527559
[TBL] [Abstract][Full Text] [Related]
31. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.
Yasutomo K; Lucas B; Germain RN
J Immunol; 2000 Sep; 165(6):3015-22. PubMed ID: 10975810
[TBL] [Abstract][Full Text] [Related]
32. Protein degradation in MHC class II antigen presentation: opportunities for immunomodulation.
Medd PG; Chain BM
Semin Cell Dev Biol; 2000 Jun; 11(3):203-10. PubMed ID: 10906277
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of major histocompatibility complex class II compartments in cortical thymic epithelial cells.
Arudchelvan Y; Nishimura Y; Tokuda N; Sawada T; Ueyama Y; Fukumoto T
Anat Rec A Discov Mol Cell Evol Biol; 2003 Sep; 274(1):798-806. PubMed ID: 12923890
[TBL] [Abstract][Full Text] [Related]
34. Thymic expression of a gastritogenic epitope results in positive selection of self-reactive pathogenic T cells.
Laurie KL; La Gruta NL; Koch N; van Driel IR; Gleeson PA
J Immunol; 2004 May; 172(10):5994-6002. PubMed ID: 15128782
[TBL] [Abstract][Full Text] [Related]
35. DM, but not cathepsin L, is required to control an aerosol infection with Mycobacterium tuberculosis.
Nepal RM; Vesosky B; Turner J; Bryant P
J Leukoc Biol; 2008 Oct; 84(4):1011-8. PubMed ID: 18591414
[TBL] [Abstract][Full Text] [Related]
36. Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice.
Sevenich L; Hagemann S; Stoeckle C; Tolosa E; Peters C; Reinheckel T
Biochimie; 2010 Nov; 92(11):1674-80. PubMed ID: 20347002
[TBL] [Abstract][Full Text] [Related]
37. The role of intracellular acidification in antigen processing.
McCoy KL; Schwartz RH
Immunol Rev; 1988 Dec; 106():129-47. PubMed ID: 3075587
[TBL] [Abstract][Full Text] [Related]
38. Exogenous antigens bind MHC class II first, and are processed by cathepsins later.
Sadegh-Nasseri S; Kim A
Mol Immunol; 2015 Dec; 68(2 Pt A):81-4. PubMed ID: 26254987
[TBL] [Abstract][Full Text] [Related]
39. Ex vivo analysis of thymic CD4 T cells in nonobese diabetic mice with tetramers generated from I-A(g7)/class II-associated invariant chain peptide precursors.
Jang MH; Seth NP; Wucherpfennig KW
J Immunol; 2003 Oct; 171(8):4175-86. PubMed ID: 14530340
[TBL] [Abstract][Full Text] [Related]
40. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.
Saegusa K; Ishimaru N; Yanagi K; Arakaki R; Ogawa K; Saito I; Katunuma N; Hayashi Y
J Clin Invest; 2002 Aug; 110(3):361-9. PubMed ID: 12163455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
